Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products>Product Directory
  Product Directory
More information
Assay & Analytical Services

deGlycIT MaxiSpin, Deglycosylates 10-100 mg
Genovis AB
Request a quote
More information
deGlycIT MicroSpin, Deglycosylates 10 x 0.5 mg
Genovis AB
Request a quote
More information
deGlycIT MicroSpin, Deglycosylates 2 x 0.5 mg
Genovis AB
Request a quote
More information
deGlycIT MicroSpin, Deglycosylates 5 x 0.5 mg
Genovis AB
Request a quote
More information
deGlycIT MidiSpin, Deglycosylates 1-10 mg
Genovis AB
Request a quote
More information
FabRICATOR, 2000 Units
Genovis AB
Request a quote
More information
FabRICATOR, 5000 Units
Genovis AB
Request a quote
More information
FabRICATOR, 8x100 Units
Genovis AB
Request a quote
More information
FabRICATOR, 96x100 Units
Genovis AB
Request a quote
More information
FabULOUS, 2000 Units
Genovis AB
Request a quote
More information
<< 1 2 3 >>
Showing Results 1 - 10 of 22
Scientific News
Themis Bioscience’s Vaccine Against Chikungunya Successful in Phase 1
Results presented at international conferences in Philadelphia and New Orleans.
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
Computer Model Sets New Precedent in Drug Discovery
New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.
UCLA Biochemists Build Largest Synthetic Molecular ‘Cage’ Ever
New nanoscale protein container could lead to synthetic vaccines and offer a way to deliver medicine inside of human cells.
Large-scale Study Raises Hopes For Development Of E. coli Vaccine
Global comparison reveals surprisingly close relation between E. coli strains that cause traveller's diarrhoea.
Typhoid Gene Unravelled
Natural resistance against typhoid fever is linked to a particular form of the HLA-DRB1 gene.
Making Vaccines More Effective In The Elderly
Compound shown to restore the immune system’s inbuilt memory.
Developing Lifesaving Vaccines in a New Way
Rutgers-led immune system research also may help reveal new asthma clues.
New Vaccine Generates Strong Immune Response Against Hepatitis C
A new hepatitis C vaccine has shown promising results in an early clinical trial at Oxford University, generating strong and broad immune responses against the virus causing the disease.
Inhaled Ebola Vaccine May Offer Long-Term Protection from Virus
A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv